Binding Compounds, Immunogenic Compounds and Peptidomimetics
AssigneePepscan Systems B.V.
InventorsPeter Timmerman, Wouter Cornelis Puijk, Jelle Wouter Slootstra, Evert Van Dijk, Robert Hans Meloen
Life of this patent
Estimating the term…
Abstract
The invention provides means and methods for producing compounds suitable for testing for the presence and/or identification of an immunogenic compound and/or a binding compound of interest. Immunogenic compounds and compositions are also herewith provided, as well as peptidomimetics of members of the cystine-knot family.
Claims57
A method for producing a compound that is suitable for testing for the presence and/or identification of an immunogenic compound and/or a binding compound, the method comprising:
- selecting at least one amino acid residue within the primary sequence of at least one proteinaceous molecule, wherein said selected amino acid residue is at least two amino acid residues located from other selected amino acid residues, if any;
- selecting at least one flanking sequence of at least one selected amino acid residue, which flanking sequence is located in the direction of the N-terminus and/or C-terminus of said at least one proteinaceous molecule, said flanking sequence having a length of between 2 and 48 amino acid residues;
- producing a peptide comprising at least one of said flanking sequences and at least two groups capable of reacting with a scaffold, said peptide having a length of at least 4 and at most 50 amino acid residues;
- and
- contacting said peptide with said scaffold in order to form at least two linkages between said peptide and said scaffold, wherein the formation of a linkage accelerates the formation of a consecutive linkage.
A peptidomimetic of a member of the cystine-knot (growth factor) family, said peptidomimetic comprising:
- a polypeptide derived from the amino acid sequence of the beta-3 hairpin (B3) loop of said cystine-knot (growth factor) family member, wherein two amino acid residues have been replaced by a first and a second cysteine residue in the polypeptide which cysteines are attached to each other via a scaffold, wherein:
- said first scaffold-attached cysteine residue is introduced at position CysIV+p located p residues C-terminal from the position that corresponds to amino acid CysIV in the wild-type B3-loop, wherein 5≦p≦12;
- said second scaffold-attached cysteine residue is introduced at position CysV-q located q residues N-terminal from the position that corresponds to amino acid CysV in the wild-type B3-loop, wherein 4≦q≦12 and wherein (p-q) is −3, −2, −1, 0, 1, 2 or 3;
- and
- the length of said polypeptide is from amino acid at position CysIV+x to amino acid at position CysV+y, wherein −5≦x≦1 and 1≦y≦6 under the provision that x+y=−1, 0, 1 or 2.
A peptidomimetic selected from the group of peptidomimetics consisting of the polypeptide TFKELVYETCRVPGAAHHADSLCTYPVATQAH (SEQ ID NO:31) attached to scaffold m-T2, the polypeptide KIQKTATFKELVYETCRVPGAAHHADSLCTYPVATQAHAGK (SEQ NO:32) attached to scaffold T4, the polypeptide TFKCLVYETVRVPGAAHHADSLYTYPVACQAH (SEQ ID NO:37) attached to scaffold m-T2, the polypeptide TFKELVYETCRVPGDAHHADSLCTYPVATQAH (SEQ ID NO:38) attached to scaffold m-T2, the polypeptide TFKELVYETCRVPGAAHHADSLCTYPVATQAH (SEQ ID NO:31) attached to scaffold T3, the polypeptide TFKELVYETCRVPGDAHHADKLCTYPVATQAH (SEQ ID NO:40) attached to scaffold m-T2, the polypeptide TFKELVYETCRVPGDAHKAIDSLCTYPVATQAH (SEQ ID NO:41) attached to scaffold m-T2, the polypeptide ESNCTMQIMRIKPHQGQHIGEMSCLQH (SEQ ID NO:42) attached to scaffold m-T2, the polypeptide EESNCTMQIMRIKPHQGQHIGEMSCLQHN (SEQ ID NO:43) attached to scaffold m-T2, the polypeptide NYRDVRFESCRLPGAPRGVNPVCSYAVALSAQ (SEQ ID NO:126) attached to scaffold m-T2, the polypeptide VVANYRDVRFESCRLPGAPRGVNPVCSYAVALSAQAAL (SEQ ID NO:35) attached to scaffold m-T2 and the polypeptide NYRDVRFESCRLPGCPRGVNPVCSYAVALSAQ
- S
- S
- NYRDVRFESCRLPGCPRGVNPVCSYAVALSAQ (SEQ ID NO:44), attached to two scaffolds m-T2.
(canceled)
Dependencies are inferred from the claim text.